News

Dvey-Aharon is an internationally known AI expert and the inventor of AEYE-DS.

Stefano Mercuri, MD, speaks about his team's August Deutman award-winning research on retinitis pigmentosa and Rho gene mutations

Alexandra Miere, MD, PhD, says oculomics is the next big thing in eye care.

Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab

Carl Awh, MD, FASRS, spoke the value of the international community of retina clinicians connecting at global meetings

Investigadores brasileños preocupados por la aparición de metástasis oculares realizaron un estudio retrospectivo y descubrieron que la frecuencia de metástasis oculares era relativamente baja, según su primer autor Matheus Senna Pereira Ogata, MD.

Evaluando los beneficios de un paquete de expansión, sus costos y riesgos asociados

Sumit Sharma, MD, sat down with Sydney Crago of Modern Retina to discuss his presentation on the 3 tyrosine kinase inhibitors currently in development for the treatment of retina conditions at the Retina Society meeting being held this year in Lisbon, Portugal.

This research builds on previous experience that stimulating nicotinic receptors can inhibit experimental myopia

Clare Bailey, MD, shared data from the multi-country study on faricimab for patients with DME and nAMD

Inflammasome Therapeutics has completed enrollment of a Phase I PK/Safety study of its new brain- and retina-penetrant drug, K9.

How retinal imaging can provide clinicians a deeper understanding of myopia

Additionally, FDA grants Fast Track Designation to brepocitinib for non-infectious uveitis.

The agency confirmed its June 2024 negative opinion after Apellis requested re-examination of EMA's initial opinion.

New research and EURETINA highlights from the director of the "underdog" eye clinic

The agency confirmed its June 2024 negative opinion after Apellis requested re-examination of the EMA's initial response

Vyznova is for the treatment of bullous keratopathy of the cornea, a sight-threatening and debilitating condition affecting the endothelial cells of the cornea.

TEPEZZA is the first and only medicine approved in Japan to treat active TED.

Nicole Eter, MD, discussed the use of a magnification implant being used in patients with geographic atrophy (GA) at from this year's EURETINA congress being held in Barcelona, Spain, which took place September 19-22, 2024.

Presented by the National Center for Children’s Vision and Eye Health at Prevent Blindness, the Bonnie Strickland Champion for Children’s Vision Award recognizes efforts by an individual or group of individuals, to improve public health approaches for children’s vision and eye health.

Challenging surgical videos from the Vit-Buckle Society symposia and data on the impact of home OCT in management of nAMD

According to the company, the center, which officially opens on Thursday, September 26, will serve as a hub for hands-on training and education in lens-based vision correction.

Moon Jeong Lee, MD, shares how volunteering in geriatric care shaped her career path.